UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 18, 2026
Vivid Seats Inc.
(Exact name of registrant as specified in its charter)
|
Delaware
(State or other
jurisdiction of incorporation)
|
001-40926
(Commission File Number)
|
86-3355184
(IRS Employer
Identification No.)
|
| |
|
|
|
24 East Washington Street, Suite 900
Chicago, Illinois
(Address of principal executive offices)
|
60602
(Zip Code)
|
| |
|
|
|
Registrant’s telephone number, including area code: (312) 291-9966
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Class A common stock, par value $0.0001 per share |
|
SEAT |
|
The Nasdaq Stock Market LLC |
| Warrants to purchase Class A common stock |
|
SEATW |
|
The Nasdaq Stock Market LLC* |
* On October 16, 2026, The Nasdaq Stock Market LLC filed a Form 25 with the Securities and
Exchange Commission (the “SEC”) to (i) delist these warrants from the Nasdaq Global Select Market, which delisting became effective on October 26, 2026, and (ii) remove these warrants from registration under Section 12(b) of the Securities Exchange
Act of 1934, which deregistration will become effective 90 days, or such shorter period as the SEC may determine, after such filing.
Indicate by check mark whether the registrant is an emerging growth company as defined in
Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to
use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement
On November 19, 2026, Vivid Seats Inc. (the “Company”), Hoya Intermediate, LLC (“Holdings”),
Hoya Midco, LLC (the “Borrower”), and certain other subsidiaries of the Company (collectively, the “Company Parties”) entered into a Transaction Support Agreement (together with the exhibits and schedules thereto, including the term
sheet attached as Exhibit A thereto, the “TSA”) with (i) certain lenders (the “Consenting Lenders”) holding a substantial majority of the aggregate outstanding principal amount of the term loans (the “Existing Term Loans”) under
the First Lien Credit Agreement, dated June 30, 2017 (as amended, restated, supplemented, or otherwise modified from time to time, the “Existing Term Loan Credit Agreement”), among Holdings, the Borrower, the lenders party thereto, and
Wilmington Savings Fund Society, FSB (as successor-in-interest to Barclays Bank PLC), as administrative agent and collateral agent, and (ii) Jefferies Capital Services, LLC, as fronting lender (the “Fronting Lender”) for the New First Out Term
Loans (as defined below).
The TSA sets forth the terms on which the parties have agreed to support and implement a
comprehensive recapitalization of the Company’s capital structure (collectively, the “Transactions”). The Transactions include, among others:
|
• |
Term Loan Exchange. Each Consenting Lender will exchange its Existing Term Loans for (i) $2,944.75 in aggregate principal amount of new
first lien, second out term loans (the “Exchanged Second Out Term Loans”) for each $10,000.00 of principal amount of Existing Term Loans held by such Consenting Lender immediately prior to the closing date of the Transactions (the “Closing
Date”) and (ii) its pro rata portion of newly issued shares of the Company’s Class A common stock (the “New Common Equity”) representing, in the aggregate, 80.0% of the Company’s Class A common stock immediately following
consummation of the Transactions (the “Term Loan Exchange”). No Consenting Lender will hold more than 19.99% of the Company’s Class A common stock immediately following consummation of the Transactions. Existing holders of the Company’s
Class A common stock will retain, in the aggregate, 20.0% of the Company’s Class A common stock immediately following consummation of the Transactions. |
|
• |
New Money Financing. The Borrower will receive $66.0 million of new first lien, first out term loans (inclusive of $6.0 million of fees
paid-in-kind) (the “New First Out Term Loans”), which will be offered on a pro rata basis to holders of Existing Term Loans that become Consenting Lenders on or prior to the date that is seven days after the TSA is posted to holders of
Existing Term Loans (or such later date as may be agreed by the Company and certain of the Backstop Parties (as defined below)). The New First Out Term Loans will be initially funded by the Fronting Lender and have been fully backstopped,
severally and not jointly, by certain Consenting Lenders (the “Backstop Parties”). |
|
• |
Other Closing Terms. The Transactions also contemplate, among other things, (i) the entry into a new credit agreement governing the New
First Out Term Loans and the Exchanged Second Out Term Loans, (ii) an amendment to the Existing Term Loan Credit Agreement (the “Closing Amendment”), (iii) the repayment of the Company Parties’ existing revolving credit facility and
intercompany senior secured credit facility, (iv) the reconstitution of the Company’s board of directors, (v) the adoption of a management incentive plan, (vi) the entry into a registration rights agreement for the New Common Equity, and (vii)
customary mutual releases, in each case on terms to be set forth in definitive documentation entered into on or prior to the Closing Date. |
Under the TSA, the Company Parties have agreed, among other things, to support and take all
commercially reasonable actions necessary to facilitate the implementation and consummation of the Transactions, to negotiate in good faith and execute the definitive documentation for the Transactions, to not solicit or pursue any alternative
transaction (subject to the right of the governing body of each Company Party to take actions consistent with its fiduciary duties), and, between the date of the TSA and the Closing Date, to comply with customary interim operating covenants.
Under the TSA, each Consenting Lender has agreed, severally and not jointly, among other
things, to support and take all commercially reasonable actions to facilitate the implementation and consummation of the Transactions, to provide all consents required for the Transactions, including the Closing Amendment, to not object to or impede
the Transactions or support any alternative restructuring of the Existing Term Loans, and to not transfer its Existing Term Loans except to a transferee that is or agrees to become bound by the TSA.
The consummation of the Transactions is subject to customary conditions, including
participation by holders of at least 99% of the Existing Term Loans, subject to reduction or waiver if agreed by the Company and certain of the Consenting Lenders (the “Minimum Participation Condition”), the execution of definitive
documentation, and the payment of fees. The TSA may be terminated by the Company or the required Consenting Lenders upon the occurrence of certain specified events, including uncured breaches, failure to meet specified milestones, and the exercise of
the fiduciary out described above. The TSA will terminate automatically if the Closing Date has not occurred by January 31, 2027 (extendable in specific circumstances to March 31, 2027).
The TSA contains customary representations, warranties, and covenants of the parties, which
were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties, and may be subject to limitations agreed upon by the parties, including being qualified by confidential disclosures. Investors should
not rely on them as characterizations of the actual state of facts. There can be no assurance that the Transactions will be consummated on the terms described herein or at all.
The foregoing description of the TSA and the Transactions does not purport to be complete
and is qualified in its entirety by reference to the full text of the TSA, including the term sheet attached as Exhibit A thereto, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 3.02 Unregistered Sales of Equity Securities
The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by
reference in this Item 3.02. Upon consummation of the Term Loan Exchange, the Company will issue the New Common Equity (approximately 45.8 million shares of Class A common stock) to the Consenting Lenders in exchange for a portion of Existing Term
Loans. Such issuance will be made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers
On November 18, 2026, the Company entered into retention agreements with certain key
employees, including each of the Company’s named executive officers (“NEOs”). The retention agreements provide for retention payments to Lawrence Fey, Joseph Thomas, Stefano Langenbacher, and Edward Pickus in the aggregate amount of $771,000,
$771,000, $771,000, and $578,000, respectively. Fifty percent of each retention payment is payable immediately, and the remaining fifty percent is payable on November 18, 2027.
If an NEO’s employment is terminated prior to November 18, 2027 by the Company for Cause (as
defined in the NEO’s employment agreement) or by the NEO without Good Reason (as defined in the NEO’s employment agreement), then the NEO will be required to repay a pro rata, after-tax portion of the first installment of the retention payment and
will forfeit the right to the second installment. If an NEO’s employment is terminated for any other reason prior to November 18, 2027, the repayment obligation with respect to the first installment of the retention payment will lapse, but the NEO
will not be entitled to receive the second installment. If a Change in Control (as defined in the Company’s 2021 Incentive Award Plan, as amended) occurs prior to November 18, 2027, the repayment obligation with respect to the first installment of
the retention payment will lapse and the second installment will become immediately payable.
Item 7.01 Regulation FD Disclosure
On November 19, 2026, the Company issued a press release announcing its entry into the TSA.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
In connection with its discussions regarding the Transactions, the Company entered into
confidentiality agreements with certain holders of Existing Term Loans pursuant to which it agreed to publicly disclose certain information provided to such holders (the “Cleansing Material”) upon the occurrence of certain events. The
Cleansing Material is furnished as Exhibit 99.2 to this Current Report on Form 8-K. The Cleansing Material was prepared as of earlier dates using then-available information solely to facilitate such discussions and speaks only as of such dates. The
Cleansing Material was not prepared with a view toward public disclosure and should not be relied upon to make an investment decision with respect to the Company. The Cleansing Material should not be regarded or relied upon as an indication that the
Company or any third party considers the Cleansing Material to be a reliable prediction of future events. The Cleansing Material includes certain values that were prepared for illustrative purposes only and are not the result of, and do not
necessarily represent, actual valuations, estimates, forecasts, or projections of the Company or any third party and should not be relied upon as such. Neither the Company nor any third party has made or makes any representation to any person
regarding the accuracy of the Cleansing Material or undertakes any obligation to publicly update or revise the Cleansing Material to reflect circumstances existing after the date on which it was prepared or conveyed or to reflect the occurrence of
future events, even in the event that any or all of the assumptions underlying the Cleansing Material are shown to be incorrect.
The information set forth under this Item 7.01, including Exhibits 99.1 and 99.2 hereto,
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.
Forward-Looking Statements
This report contains “forward-looking statements” within the meaning of Section 27A of the
Securities Act and Section 21E of the Exchange Act regarding future events and trends and the future results of the Company and its subsidiaries. Words such as “anticipate,” “believe,” “can,” “continue,” “could,” “design,” “estimate,” “expect,”
“forecast,” “future,” “goal,” “intend,” “likely,” “may,” “plan,” “project,” “propose,” “seek,” “should,” “target,” “will” and “would,” as well as similar expressions that predict or indicate future events and trends or do not relate to historical
matters, are intended to identify such forward-looking statements. The Company has based these forward-looking statements largely on its current expectations, estimates, forecasts, and projections about future events and financial trends that it
believes may affect its business, financial condition, and results of operations. While the Company believes such information forms a reasonable basis for such statements, such information may be limited or incomplete, and the Company’s statements
should not be read to indicate that it has conducted an exhaustive inquiry into, or review of, all potentially available relevant information. Forward-looking statements are not guarantees of future performance, conditions, or results, and are
subject to risks, uncertainties, and assumptions that can be difficult to predict and/or are outside of the Company’s control. Therefore, actual results may differ materially from those contemplated by any forward-looking statements. Important
factors that could cause or contribute to such differences include, but are not limited to: the ability of the parties to consummate the Transactions on the terms or timeline proposed, or at all, including the satisfaction of the Minimum
Participation Condition and other closing conditions; the possibility that the TSA is terminated prior to consummation of the Transactions; and other factors discussed in the “Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” sections of the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, as well as in the Company’s press releases and other filings with the Securities and Exchange
Commission (the “SEC”). You should not place undue reliance on forward-looking statements, which speak only as of the date of this report (or, in the case of statements incorporated by reference herein, as of the date of the incorporated
statement). Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements contained in this report, whether as a result of new information, future events, or otherwise.
|
Item 9.01 |
Financial Statements and Exhibits |
(d) Exhibits
| Exhibit No. |
|
Description |
| 10.1* |
|
Transaction Support Agreement, dated as of November 19, 2026, by and among Vivid Seats Inc., the other Company Parties
party thereto, the Consenting Lenders party thereto, and Jefferies Capital Services, LLC, as Fronting Lender |
| 99.1 |
|
Press release issued by Vivid Seats Inc., dated November 19, 2026 |
| 99.2 |
|
Cleansing Material |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL Document) |
*Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation
S-K, and certain identified information has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish a copy of any omitted schedule or exhibit to the SEC upon request.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
Vivid Seats Inc. |
| |
|
| Date: November 19, 2026 |
By: |
/s/ Joseph Thomas |
| |
|
Joseph Thomas |
| |
|
Chief Financial Officer |
Exhibit 99.1
FOR IMMEDIATE RELEASE
Vivid Seats Enters Into Transaction Support Agreement for Comprehensive Recapitalization
Transaction Reduces Net Debt by $232 Million, Provides $66 Million of New First Lien, First Out Term Loans1,
and Extends Term Loan Maturities to 2032
CHICAGO, November 19, 2026 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (Nasdaq: SEAT) (“Vivid Seats”), a leading
marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today announced that it has entered into a Transaction Support Agreement (the “TSA”)
with an ad hoc group comprising a substantial majority of its term loan lenders to implement a comprehensive recapitalization.
The transaction represents a significant deleveraging of Vivid Seats’ balance sheet, reducing net debt by
approximately $232 million while providing $66 million of new first lien, first out term loans (inclusive of $6 million of fees paid-in-kind) and extending remaining term loan maturities to 2032. Together, these measures enhance liquidity and financial flexibility and position Vivid Seats to execute on its long-term strategic objectives.
“We are pleased to have reached this agreement, which provides a durable capital structure that will support
long-term equity value creation as we continue executing against our strategic objectives,” said Lawrence Fey, Chief Executive Officer of Vivid Seats. “We have leading technology, proprietary data, a compelling value proposition, and an exciting
product roadmap. With our new capital structure, we can deliver the most rewarding ticket-buying experience for fans while creating value for our stakeholders.”
Transaction Details
The table below summarizes Vivid Seats’ current and pro forma capital structure following completion of the
transaction.2
| |
9/30/2026 |
Pro Forma |
| Total Debt |
$387mm |
$180mm |
| Net Debt |
$342mm |
~$110mm |
| Net Leverage |
~9.24x |
~2.97x |
|
Term Loan Maturity
|
Feb. 2029 |
Jan. 2032 |
Approximately $273 million of secured debt will be exchanged for approximately 45.8 million newly issued shares
of Class A common stock (~80% of the common equity following completion of the transaction). Existing shareholders will continue to hold approximately 11.5 million currently outstanding shares of Class A common stock (~20% of the common equity
following completion of the transaction).
1 Inclusive of $6 million of fees paid-in-kind.
2 Pro forma figures based on management’s estimate
of net debt and cash assuming a closing date in January 2027 and assuming 100% lender participation; net leverage is based on the midpoint of 2026 adjusted EBITDA guidance.
The transaction is expected to close in the first quarter of 2027, subject to the satisfaction or waiver of
certain customary conditions set forth in the TSA, including the execution of definitive transaction documentation and the payment of applicable transaction fees and expenses.
For more information about the transaction, see the Current Report on Form 8-K filed today by Vivid Seats with
the Securities and Exchange Commission.
Advisors
Latham & Watkins LLP is serving as legal advisor, Moelis & Company LLC is serving as investment banker,
and FTI Consulting is serving as financial and communications advisor to Vivid Seats in connection with the transaction. Gibson, Dunn & Crutcher LLP is serving as legal advisor and Centerview Partners LLC is serving as investment banker to the ad
hoc group of term loan lenders.
About Vivid Seats
Founded in 2001, Vivid Seats (Nasdaq: SEAT) is a leading online ticket marketplace connecting fans to the live
events, artists, and teams they love. Vivid Seats is committed to delivering the most rewarding ticket-buying experience for fans through competitive everyday pricing backed by its Lowest Price Guarantee, an industry-leading rewards program, and
award-winning customer service. The Chicago-based company offers one of the widest selections of live events across North America, powered by proprietary technology that makes discovering and buying tickets simple, affordable, and reliable. Learn
more by downloading the Vivid Seats app or visiting vividseats.com.
Forward-Looking Statements:
This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “can,” “continue,” “could,” “design,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “plan,” “project,” “propose,” “seek,” “should,” “target,”
“will,” and “would,” as well as similar expressions that predict or indicate future events or do not relate to historical matters, are intended to identify such forward-looking statements. Such forward-looking statements may relate to, without
limitation: the expected timing of closing of the transaction; the anticipated benefits of the transaction; and Vivid Seats’ pro forma capital structure following completion of the transaction. Forward-looking statements are not guarantees of future
performance, conditions, or results, and are subject to risks and uncertainties that can be difficult to predict and/or outside of Vivid Seats’ control. Therefore, actual results may differ materially from those contemplated by any such
forward-looking statements. Such risks and uncertainties include, but are not limited to: the parties’ ability to consummate the transaction on the terms or timeline proposed, or at all, and to realize the anticipated benefits thereof; the effects of
disruption from the transaction making it more difficult to maintain business, financing, and operational relationships; and other factors discussed in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of
Operations” sections of Vivid Seats’ most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, as well as in Vivid Seats’ press releases and other filings with the Securities and Exchange Commission. Except as required by
applicable law, Vivid Seats undertakes no obligation to update or revise any such forward-looking statements, which speak only as of the date of this press release.
Contact:
Investors
Investors@vividseats.com
Media
Press@vividseats.com
2